These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32203424)

  • 1. Can low intensity shockwave therapy match the efficacy of phosphodiesterase-5 inhibitors for erectile dysfunction treatment? A pooled data analysis from two randomized clinical trials.
    Mykoniatis I; Kalyvianakis D; Kapoteli P; Zilotis F; Fournaraki A; Poulios E; Hatzichristou D
    Int J Impot Res; 2021 Apr; 33(3):383-385. PubMed ID: 32203424
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment.
    Kalyvianakis D; Memmos E; Mykoniatis I; Kapoteli P; Memmos D; Hatzichristou D
    J Sex Med; 2018 Mar; 15(3):334-345. PubMed ID: 29396020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
    Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
    Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal shockwave therapy in the treatment of erectile dysfunction: a prospective, randomized, double-blinded, placebo controlled study.
    Yee CH; Chan ES; Hou SS; Ng CF
    Int J Urol; 2014 Oct; 21(10):1041-5. PubMed ID: 24942563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?
    Patel P; Fode M; Lue T; Ramasamy R
    Eur Urol Focus; 2019 Jul; 5(4):526-528. PubMed ID: 30777724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Rosen RC; Shaw JW
    Int J Impot Res; 2006; 18(6):570-1; author reply 572-3. PubMed ID: 17075585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimization of the use of phosphodiesterase-5 inhibitors].
    Pushkar' DIu; Segal AS
    Urologiia; 2012; (4):79-80, 82. PubMed ID: 23116030
    [No Abstract]   [Full Text] [Related]  

  • 8. PDE5 inhibitors and their applications.
    Giovannoni MP; Vergelli C; Graziano A; Dal Piaz V
    Curr Med Chem; 2010; 17(24):2564-87. PubMed ID: 20491634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
    Kitrey ND; Gruenwald I; Appel B; Shechter A; Massarwa O; Vardi Y
    J Urol; 2016 May; 195(5):1550-1555. PubMed ID: 26694904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Low-Intensity Extracorporeal Shockwave Therapy on Erectile Dysfunction: A Systematic Review and Meta-Analysis.
    Clavijo RI; Kohn TP; Kohn JR; Ramasamy R
    J Sex Med; 2017 Jan; 14(1):27-35. PubMed ID: 27986492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Berner MM; Kriston L; Harms A
    Int J Impot Res; 2006; 18(3):229-35. PubMed ID: 16239897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
    Fojecki GL; Tiessen S; Osther PJ
    World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-intensity extracorporeal shockwave therapy for erectile dysfunction: An update].
    Zou ZJ; Lu YP
    Zhonghua Nan Ke Xue; 2016 Jul; 22(7):654-658. PubMed ID: 28965387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials.
    Liao X; Qiu S; Bao Y; Wang W; Yang L; Wei Q
    World J Urol; 2019 Jun; 37(6):1061-1074. PubMed ID: 30523399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
    Srini VS; Reddy RK; Shultz T; Denes B
    Can J Urol; 2015 Feb; 22(1):7614-22. PubMed ID: 25694008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phosphodiesterase 5 inhibition in erectile dysfunction. Long-term administration without therapeutic advantage].
    MMW Fortschr Med; 2009 Jan; 151(1-2):50-1. PubMed ID: 19227645
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale.
    Rosen RC; Allen KR; Ni X; Araujo AB
    Eur Urol; 2011 Nov; 60(5):1010-6. PubMed ID: 21855209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials.
    Ding H; Du W; Wang H; Zhang L; Wang Z; Du C; Tao Y
    Urology; 2012 Jul; 80(1):134-9. PubMed ID: 22497982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantation.
    Lasaponara F; Sedigh O; Pasquale G; Bosio A; Rolle L; Ceruti C; Timpano M; Negro CL; Paradiso M; Abbona A; Segoloni GP; Fontana D
    J Sex Med; 2013 Nov; 10(11):2798-814. PubMed ID: 23346948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction.
    Hamzehnejadi M; Ranjbar Tavakoli M; Abiri A; Ghasempour A; Langarizadeh MA; Forootanfar H
    Sex Med Rev; 2022 Jul; 10(3):376-391. PubMed ID: 35370122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.